Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis

Annals of Neurology

Volumn 34, Issue 2, 1993, Pages 130-135

  Vriesendorp, Francine J ^a,c   Mishu, Ban ^b   Blaser, Martin J ^b   Koski, Carol L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MONOSIALOGANGLIOSIDE; MYELIN;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; COMPLEMENT FIXATION; CONTROLLED STUDY; ELECTROMYOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; NERVE FIBER DEGENERATION; PARALYSIS; PERIPHERAL NERVE; PRIORITY JOURNAL; QUADRIPLEGIA; RANVIER NODE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES; ANTIBODIES, BACTERIAL; AUTOANTIBODIES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CASE-CONTROL STUDIES; FEMALE; G(M1) GANGLIOSIDE; GANGLIOSIDES; HUMAN; MALE; MIDDLE AGE; MYELIN SHEATH; POLYRADICULONEUROPATHY; PROGNOSIS; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027176630     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410340206     Document Type: Article

References (30)

1. The Guillain‐Barré Syndrome Study Group. Plasmapheresis and Guillain‐Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis
2. Guillain‐Barré syndrome and Campylobacter jejuni: a serological study
3. A prospective study of acute idiopathic neuropathy. II: Antecedent events
4. Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain‐Barré syndrome
5. Axonal Guillain‐Barré
6. Serum antibodies to gangliosides in Guillain‐Barré syndrome
7. Acute axonal polyneuropathy associated with anti‐GM1 antibodies following Campylobacter enteritis
8. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain‐Barré syndrome
9. Anti‐GM1 antibodies in patients with Guillain‐Barré syndrome
10. Anti‐GM1 IgA antibodies in Guillain‐Barré syndrome
11. The Dutch Guillain‐Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain‐Barré syndrome
12. Experimental conduction block induced by serum from a patient with anti‐GM1 antibodies
13. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto‐N‐tetraose associated with human motor neuron disease
14. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis
15. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
16. Criteria for diagnosis of Guillain‐Barré syndrome
17. Anti‐peripheral nerve myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation
18. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme‐linked immunosorbent assay
19. Superficial antigens of Campylobacter (Vibrio) fetus: characterization of an antiphagocytic component
20. Lectin typing of Campylobacter isolates
21. The spectrum of neurologic disease associated with anti‐GM1 antibodies
22. Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden
23. Guillain‐Barré syndrome associated with Campylobacter infection
24. Guillain‐Barré syndrome associated with Campylobacter infection
25. The Guillain‐Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis
26. Guillain‐Barré syndrome associated with Campylobacter infection
27. Severe axonal form of Guillain‐Barré syndrome associated with IgG anti‐GD1a antibodies